MRI evidence of extraocular muscle atrophy and fatty replacement in myasthenia gravis.


Journal

Neuroradiology
ISSN: 1432-1920
Titre abrégé: Neuroradiology
Pays: Germany
ID NLM: 1302751

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 21 04 2021
accepted: 11 06 2021
pubmed: 8 7 2021
medline: 30 9 2021
entrez: 7 7 2021
Statut: ppublish

Résumé

The aim of the study was to evaluate extraocular muscle (EOM) atrophy and fatty replacement in ocular myasthenia gravis (OMG) and generalized myasthenia gravis (GMG) patients with chronic and untreated ocular symptoms or with inadequate response to immunotherapy and unprovoked ocular exacerbations despite chronic immunotherapy. Nineteen patients with either OMG or GMG and 19 healthy age-matched controls underwent an orbital MRI. Visually obvious muscle atrophy and muscle fatty replacement were evaluated by two raters independently. Maximum thickness of EOM was measured. Measurements of the muscles of each participant were added up, in order to calculate the total thickness. Eleven patients suffered from AChR-positive GMG, and 8 patients from OMG. All patients had chronic ocular symptoms or inadequate response to corticosteroids and unprovoked ocular exacerbations in spite of immunotherapy. Fatty replacement was reported in 6/19 (31.6%) patients and 0/19 (0%) controls (p = 0.02). Obvious atrophy in at least one muscle was reported in 8/19 (42.1%) patients and 1/19 (5.3%) controls (p = 0.019). Statistically significant differences between the two groups were also found in the mean total thickness, as well as in the thickness of superior recti, levator palpebrae, inferior recti, and superior oblique muscles. EOM atrophy and fatty replacement were seen frequently in our series of MG patients with treatment difficulties and frequent relapses of ocular involvement.

Identifiants

pubmed: 34232334
doi: 10.1007/s00234-021-02753-4
pii: 10.1007/s00234-021-02753-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1531-1538

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Drachman Daniel (2016) Myasthenia gravis. Semin Neurol 36:419–424. https://doi.org/10.1055/s-0036-1586265
doi: 10.1055/s-0036-1586265 pubmed: 27704496
Farrugia ME, Robson MD, Clover L, Anslow P, Newsom-Davis J, Kennett R, Hilton-Jones D, Matthews PM, Vincent A (2006) MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Brain. 1481–1492. https://doi.org/10.1093/brain/awl095
Zouvelou V, Rentzos M, Toulas P, Evdokimidis I (2011) MRI evidence of early muscle atrophy in MuSK positive myasthenia gravis. J Neuroimaging 21(3):303–305. https://doi.org/10.1111/j.1552-6569.2009.00456.x
doi: 10.1111/j.1552-6569.2009.00456.x pubmed: 20002967
Takahashi H, Kawaguchi N, Ito S, Nemoto Y, Hattori T, Kuwabara S (2010) Is tongue atrophy reversible in anti-MuSK myasthenia gravis? Six-year observation. J Neurol Neurosurg Psychiatry 81:701–702. https://doi.org/10.1136/jnnp.2009.171793
doi: 10.1136/jnnp.2009.171793 pubmed: 20522876
Benveniste O, Jacobson L, Farrugia ME, Clover L, Vincent A (2005) MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo. J Neuroimmunol 170:41–48. https://doi.org/10.1016/j.jneuroim.2005.08.016
doi: 10.1016/j.jneuroim.2005.08.016 pubmed: 16213598
Ortube MC, Bhola R, Demer JL (2006) Orbital magnetic resonance imaging of extraocular muscles in chronic progressive external ophthalmoplegia: specific diagnostic findings. J AAPOS 10:414–418. https://doi.org/10.1016/j.jaapos.2006.04.012
doi: 10.1016/j.jaapos.2006.04.012 pubmed: 17070475 pmcid: 1850670
Okamoto K, Ito J, Tokiguchi S, Furusawa T (1996) Atrophy of bilateral extraocular muscles. CT and clinical features of seven patients. J Neuroophthalmol 16:286–288
doi: 10.1097/00041327-199612000-00012
Chan JW, Orrison WW (2007) Ocular myasthenia: a rare presentation with MuSK antibody and bilateral extraocular muscle atrophy. Br J Ophthalmol 91:842–843. https://doi.org/10.1136/bjo.2006.108498
doi: 10.1136/bjo.2006.108498 pubmed: 17510484 pmcid: 1955582
Ricciardi D, Todisco V, Tedeschi G, Cirillo G (2020) Anti-MuSK ocular myasthenia with extrinsic ocular muscle atrophy: a new clinical phenotype? Neurol Sci 41:221–223. https://doi.org/10.1007/s10072-019-04038-4
doi: 10.1007/s10072-019-04038-4 pubmed: 31422505
Keene KR, van Vught L, van de Velde NM et al (2021) The feasibility of quantitative MRI of extraocular muscles in myasthenia gravis and Grave’s orbitopathy. NMR Biomed 34:e4407. https://doi.org/10.1002/nbm.4407
doi: 10.1002/nbm.4407 pubmed: 32893386
Gratton SM, Herro A, Bemudez-Magner JA, Guy J (2014) Atrophy and fibrosis of extra-ocular muscles in anti-acetylcholine receptor antibody myasthenia gravis. Open J Opthalmol 4:117–119
doi: 10.4236/ojoph.2014.44019
Erickson SJ, Cox IH, Hyde JS, Carrera GF, Strandt JA, Estkowski LD (1991) Effect of tendon orientation on MR imaging signal intensity: a manifestation of the “magic angle” phenomenon. Radiology 181:389–392. https://doi.org/10.1148/radiology.181.2.1924777
doi: 10.1148/radiology.181.2.1924777 pubmed: 1924777
Gold GE, Suh B, Sawyer-Glover A, Beaulieu C (2004) Musculoskeletal MRI at 3.0 T: initial clinical experience. AJR Am J Roentgenol 183:1479–1486. https://doi.org/10.2214/ajr.183.5.1831479
doi: 10.2214/ajr.183.5.1831479 pubmed: 15505324
Bridge P, Fielding A, Rowntree P, Pullar A (2016) Intraobserver Variability: should we worry? J Med Imaging Radiat Sci 47:217–220. https://doi.org/10.1016/j.jmir.2016.06.004
doi: 10.1016/j.jmir.2016.06.004 pubmed: 31047285
Weidauer S, Hofmann C, Wagner M et al (2019) Neuroradiological and clinical features in ophthalmoplegia. Neuroradiology 61:365–387. https://doi.org/10.1007/s00234-019-02183-3
doi: 10.1007/s00234-019-02183-3 pubmed: 30747268
Liu X, Su Y, Jiang M, Fang S, Huang Y, Li Y, Zhong S, Wang Y, Zhang S, Wu Y, Sun J, Fan X, Zhou H (2021) Application of magnetic resonance imaging in the evaluation of disease activity in Graves’ ophthalmopathy. Endocr Pract 27:198–205. https://doi.org/10.1016/j.eprac.2020.09.008
doi: 10.1016/j.eprac.2020.09.008 pubmed: 33658136
Aydin K, Güven K, Sencer S et al (2003) A new MRI method for the quantitative evaluation of extraocular muscle size in thyroid ophthalmopathy. Neuroradiology 45:184–187. https://doi.org/10.1007/s00234-002-0930-8
doi: 10.1007/s00234-002-0930-8 pubmed: 12684723
Mavridis T, Velonakis G, Zouvelou V (2020) Painful diplopia: do not forget thyroid-associated ophthalmopathy. Am J Med S0002–9343(20):30781–30786. https://doi.org/10.1016/j.amjmed.2020.08.009
doi: 10.1016/j.amjmed.2020.08.009
Ferreira TA, Saraiva P, Genders SW, Buchem MV, Luyten GPM, Beenakker JW (2018) CT and MR imaging of orbital inflammation. Neuroradiology 60:1253–1266. https://doi.org/10.1007/s00234-018-2103-4
doi: 10.1007/s00234-018-2103-4 pubmed: 30310941 pmcid: 6244997
Klingenstein A, Garip-Kuebler A, Priglinger S, Hintschich C, Mueller-Lisse UG (2021) Morphologic cross-sectional imaging features of IgG4-related orbitopathy in comparison to ocular adnexal lymphoma. Clin Ophthalmol 15:1119–1127. https://doi.org/10.2147/OPTH.S299655
doi: 10.2147/OPTH.S299655 pubmed: 33737803 pmcid: 7966298
Yang HK, Kim JH, Hwang JM (2020) Magnetic resonance imaging in 14 patients with congenital oculomotor nerve palsy. Clin Neuroradiol 30:237–242. https://doi.org/10.1007/s00062-019-00781-5
doi: 10.1007/s00062-019-00781-5 pubmed: 30997520
Politi LS, Bianchi Marzoli S, Godi C, Panzeri M, Ciasca P, Brugnara G, Castaldo A, Di Bella D, Taroni F, Nanetti L, Mariotti C (2016) MRI evidence of cerebellar and extraocular muscle atrophy differently contributing to eye movement abnormalities in SCA2 and SCA28 diseases. Invest Ophthalmol Vis Sci 57:2714–2720. https://doi.org/10.1167/iovs.15-18732
doi: 10.1167/iovs.15-18732 pubmed: 27196319
Gong Q, Janowski M, Tang H, Yang Q, Wei H, Zhou X, Liu L (2017) Magnetic resonance imaging of the functional anatomy of the superior oblique muscle in patients with primary superior oblique overaction. Eye (Lond) 31:588–592. https://doi.org/10.1038/eye.2016.274
doi: 10.1038/eye.2016.274
Geng Bertie, Xiao Wu, Malhotra Ajay (2019) Lateral rectus atrophy in cavernous sinus thrombosis. Clin Neuroradiol 29:371–374. https://doi.org/10.1007/s00062-018-0729-6
doi: 10.1007/s00062-018-0729-6 pubmed: 30341446

Auteurs

Georgios Velonakis (G)

2nd Department of Radiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Vassilis E Papadopoulos (VE)

1st Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, Eginition Hospital, 74 Vas. Sophias Ave., 11528, Athens, Greece.

Efstratios Karavasilis (E)

2nd Department of Radiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Dimitrios K Filippiadis (DK)

2nd Department of Radiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Vasiliki Zouvelou (V)

1st Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, Eginition Hospital, 74 Vas. Sophias Ave., 11528, Athens, Greece. vzouvelu@med.uoa.gr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH